These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18195350

  • 1. Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task.
    Bubenikova-Valesova V, Stuchlik A, Svoboda J, Bures J, Vales K.
    Proc Natl Acad Sci U S A; 2008 Jan 22; 105(3):1061-6. PubMed ID: 18195350
    [Abstract] [Full Text] [Related]

  • 2. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A, Vales K.
    Behav Brain Res; 2005 Apr 15; 159(1):163-71. PubMed ID: 15795010
    [Abstract] [Full Text] [Related]

  • 3. Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats.
    Vales K, Bubenikova-Valesova V, Klement D, Stuchlik A.
    Neurosci Res; 2006 Aug 15; 55(4):383-8. PubMed ID: 16712995
    [Abstract] [Full Text] [Related]

  • 4. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
    Ishiyama T, Tokuda K, Ishibashi T, Ito A, Toma S, Ohno Y.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):160-70. PubMed ID: 17662268
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I, Weiner I.
    Psychopharmacology (Berl); 2003 Apr 31; 166(4):333-42. PubMed ID: 12599023
    [Abstract] [Full Text] [Related]

  • 9. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ, Schotte A, Docter GJ, Voorn P.
    Synapse; 1998 Apr 31; 28(4):302-12. PubMed ID: 9517839
    [Abstract] [Full Text] [Related]

  • 10. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
    O'Neill MF, Hicks CA, Shaw G, Parameswaran T, Cardwell GP, O'Neill MJ.
    J Pharmacol Exp Ther; 1998 Dec 31; 287(3):839-46. PubMed ID: 9864262
    [Abstract] [Full Text] [Related]

  • 11. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T.
    Jpn J Pharmacol; 1994 Oct 31; 66(2):181-9. PubMed ID: 7532732
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
    Kitaichi K, Yamada K, Yoneda Y, Ogita K, Hasegawa T, Furukawa H, Nabeshima T.
    Life Sci; 1995 Oct 31; 56(7):531-43. PubMed ID: 7532775
    [Abstract] [Full Text] [Related]

  • 14. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
    Horisawa T, Ishibashi T, Nishikawa H, Enomoto T, Toma S, Ishiyama T, Taiji M.
    Behav Brain Res; 2011 Jun 20; 220(1):83-90. PubMed ID: 21277905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z, Huang M, Prus AJ, Dai J, Meltzer HY.
    Brain Res; 2007 Feb 23; 1134(1):70-8. PubMed ID: 17207474
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA, Niemegeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF.
    J Pharmacol Exp Ther; 1988 Feb 23; 244(2):685-93. PubMed ID: 2450200
    [Abstract] [Full Text] [Related]

  • 19. Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
    Gacsályi I, Nagy K, Pallagi K, Lévay G, Hársing LG, Móricz K, Kertész S, Varga P, Haller J, Gigler G, Szénási G, Barkóczy J, Bíró J, Spedding M, Antoni FA.
    Neuropharmacology; 2013 Jan 23; 64():254-63. PubMed ID: 22824189
    [Abstract] [Full Text] [Related]

  • 20. The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.
    Skrebuhhova-Malmros T, Pruus K, Rudissaar R, Allikmets L, Matto V.
    Pharmacol Biochem Behav; 2000 Oct 23; 67(2):339-43. PubMed ID: 11124399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.